by Michelle Ly | Mar 24, 2011
Renal disease threatens approximately 2 million Canadians nationwide. The Kidney Foundation of Canada estimates that each day, an average of 14 Canadians learn that their kidneys have failed. Most diseases of the kidneys affect the nephrons, the functional unit of the...
by Michelle Ly | Feb 14, 2011
In previous posts, I discussed the use of cell therapy, specifically the application of allogenic or autologous hematopoietic stem cells (HSCs), as a way to repopulate blood cell lineages to normal levels post-treatment in patients suffering from certain types of...
by Stem Cell Network | Jan 27, 2011
Earlier this week, many of the world’s leading scientists engaged in developing stem cell-based treatments for Amyotrophic Lateral Sclerosis (ALS) or Motor Neuron Disease (MND) met for the first time as a group to share their work. Held in New York, the meeting was...
by Stem Cell Network | Jan 12, 2011
In an article in the Globe and Mail this past weekend, reporter Carolyn Abraham provided an interesting and under-reported glimpse into the cosmetics industry use of stem cells to market their products. She notes: “In science, ‘stem cell’ has been...
by Michelle Ly | Nov 29, 2010
I was having my bathroom renovated a few months ago and got into a discussion with my contractor about work. I mentioned that I had done some work with the BC Cancer Research Centre and other biomedical research institutes. His comment was, “Cancer research? So do you...
by Paul Krzyzanowski | Nov 17, 2010
In a previous post, Chris Kamel recently reviewed the Nature article about direct creation of blood progenitors from skin fibroblasts as discovered by Mick Bhatia’s research group. The fascinating thing about this article is the potential for enabling autologous...
Comments